Case Study Corner: LNP Formulation

04.26.2023

Your biggest challenges inspire us. That's why Emergent supports innovative drug makers that make the seemingly impossible possible. In our latest blog series, Case Study Corner, discover how we've helped our clients overcome their biggest challenges during the development and manufacturing process.

Summary: A mid size biotech company partnered with Emergent to characterize a multi-step lipid nanoparticle formulation process for a Phase III mRNA-LNP vaccine.

20211111-EBSI_Gaithersburg-0047-of-0052_9538NIKON Z 7-RS

Emergent CDMO

Case Studies Development Services Nanoparticles

11.19.2021

Finding the Right CDMO Partner for Tech Transfer

Regardless of where a drug candidate is in the development pipeline, performing a technology transfer (tech transfer) presents...

READ MORE

03.14.2022

Streamlining Your Process Development Journey to GMP Manufacturing

Many CDMOs specialize in certain parts of the drug development lifecycle. Meanwhile, integrated turn-key offerings that support...

READ MORE

08.19.2021

Benefits of RABS and Isolator Technology in a Changing Regulatory Landscape

Mitigating risk is a key consideration for biopharmaceutical companies when planning their clinical trial material and/or drug...

READ MORE